Related Experiment Video
Updated: Jul 2, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Effect of Hemodialysis With Citrate on Vascular Calcification
W Charles O'Neill1, Jose Navarrete1, Michelle Young1
1Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Insights
Citrate in hemodialysis (HD) unexpectedly accelerated vascular calcification in patients with end-stage renal disease (ESRD). This study found increased medial arterial calcification progression with citrate-containing HD solutions, highlighting potential risks.
Area of Science:
- Nephrology
- Vascular Biology
- Biomineralization
Background:
- Vascular calcification is common in hemodialysis (HD) patients with end-stage renal disease (ESRD), leading to poor clinical outcomes.
- Citrate, sometimes used in HD solutions, was hypothesized to inhibit vascular calcification.
Purpose of the Study:
- To investigate the effect of citrate in HD solutions on the progression of medial arterial calcification in female ESRD patients.
Main Methods:
- A cross-over study involving 28 female HD patients with pre-existing breast arterial calcification (BAC).
- Patients received HD with and without citrate dialysate for 1 year each, with BAC measured every 6 months.
- Citrate levels were measured in calcified human arteries.
Main Results:
- HD with citrate significantly increased post-HD plasma citrate levels.
- Progression of BAC was substantially greater during citrate HD compared to non-citrate HD (47 vs. 9 mm/yr).
- Citrate was detected in calcified arteries and correlated with the degree of calcification.
Conclusions:
- Citrate in HD unexpectedly promoted vascular calcification, contrary to the initial hypothesis.
- The findings suggest citrate may enhance biomineralization, similar to its role in bone formation.
- Further research is needed to assess the clinical implications of citrate-induced vascular calcification in HD patients.
Introduction:
Vascular calcification, specifically medial calcification, is prevalent in patients undergoing hemodialysis (HD) and leads to poor outcomes. Citrate is present in some HD solutions and could potentially inhibit vascular calcification. This was examined by comparing the progression of medial arterial calcification, as measured using mammography, in female patients with end-stage renal disease (ESRD) undergoing HD with and without citrate.
Methods:
In a cross-over study, 28 female chronic in-center HD patients with preexisting breast arterial calcification (BAC) underwent HD using dialysate with or without citrate, each for 1 year with BAC measured at 6-month intervals. In addition, citrate was measured in calcified human arteries.
Results:
HD with citrate increased post-HD plasma citrate over 200% with no changes in pre-HD levels of citrate, calcium (Ca), or phosphate. Progression of BAC was significantly greater during citrate HD (47, interquartile range [IQR]:10-124 vs. 9 , IQR: -4 to 34 mm/yr, P = 0.0005), with 79% of subjects having greater progression during citrate HD. Citrate was present in calcified human arteries and correlated with the degree of calcification (r = 0.91).
Conclusion:
HD with citrate unexpectedly promoted vascular calcification, which could not be explained by other dialysis parameters or changes in mineral metabolism. In addition, citrate was associated with vascular calcifications at levels approaching those reported in bone. The results are consistent with known effects of citrate to promote biomineralization and bone formation. Further studies are needed to determine whether this effect of citrate leads to adverse clinical outcomes in patients undergoing HD and occurs with other therapeutic uses of citrate.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

